TGF	B-GENE
-	I-GENE
beta1	E-GENE
,	O
but	O
not	O
bone	O
morphogenetic	O
proteins	O
,	O
activates	O
Smad1	S-GENE
/	O
5	S-GENE
pathway	O
in	O
primary	O
human	O
macrophages	O
and	O
induces	O
expression	O
of	O
proatherogenic	O
genes	O
.	O


Macrophages	O
are	O
responsible	O
for	O
the	O
control	O
of	O
inflammation	O
and	O
healing	O
,	O
and	O
their	O
malfunction	O
results	O
in	O
cardiometabolic	O
disorders	O
.	O
TGF	B-GENE
-	I-GENE
beta	E-GENE
is	O
a	O
pleiotropic	O
growth	O
factor	O
with	O
dual	O
(	O
protective	O
and	O
detrimental	O
)	O
roles	O
in	O
atherogenesis	O
.	O


We	O
have	O
previously	O
shown	O
that	O
in	O
human	O
macrophages	O
,	O
TGF	B-GENE
-	I-GENE
beta1	E-GENE
activates	O
Smad2	S-GENE
/	O
3	S-GENE
signaling	O
and	O
induces	O
a	O
complex	O
gene	O
expression	O
program	O
.	O


However	O
,	O
activated	O
genes	O
were	O
not	O
limited	O
to	O
known	O
Smad2	S-GENE
/	O
3	S-GENE
-	O
dependent	O
ones	O
,	O
which	O
prompted	O
us	O
to	O
study	O
TGF	B-GENE
-	I-GENE
beta1	E-GENE
-	O
induced	O
signaling	O
in	O
macrophages	O
in	O
detail	O
.	O


Analysis	O
of	O
Id3	S-GENE
regulatory	O
sequences	O
revealed	O
a	O
novel	O
enhancer	O
,	O
located	O
between	O
+	O
4517	O
and	O
4662	O
bp	O
,	O
but	O
the	O
luciferase	O
reporter	O
assay	O
demonstrated	O
that	O
this	O
enhancer	O
is	O
not	O
Smad2	S-GENE
/	O
3	S-GENE
dependent	O
.	O


Because	O
Id3	S-GENE
expression	O
is	O
regulated	O
by	O
Smad1	S-GENE
/	O
5	S-GENE
in	O
endothelial	O
cells	O
,	O
we	O
analyzed	O
activation	O
of	O
Smad1	S-GENE
/	O
5	S-GENE
in	O
macrophages	O
.	O


We	O
demonstrate	O
here	O
for	O
the	O
first	O
time	O
,	O
to	O
our	O
knowledge	O
,	O
that	O
TGF	B-GENE
-	I-GENE
beta1	E-GENE
,	O
but	O
not	O
BMPs	O
,	O
activates	O
Smad1	S-GENE
/	O
5	S-GENE
in	O
macrophages	O
.	O


We	O
show	O
that	O
an	O
ALK5	S-GENE
/	O
ALK1	S-GENE
heterodimer	O
is	O
responsible	O
for	O
the	O
induction	O
of	O
Smad1	S-GENE
/	O
5	S-GENE
signaling	O
by	O
TGF	B-GENE
-	I-GENE
beta1	E-GENE
in	O
mature	O
human	O
macrophages	O
.	O


Activation	O
of	O
Smad1	S-GENE
/	O
5	S-GENE
by	O
TGF	B-GENE
-	I-GENE
beta1	E-GENE
induces	O
not	O
only	O
Id3	S-GENE
,	O
but	O
also	O
HAMP	S-GENE
and	O
PLAUR	S-GENE
,	O
which	O
contribute	O
to	O
atherosclerotic	O
plaque	O
vulnerability	O
.	O


We	O
suggest	O
that	O
the	O
balance	O
between	O
Smad1	S-GENE
/	O
5	S-GENE
-	O
and	O
Smad2	S-GENE
/	O
3	S-GENE
-	O
dependent	O
signaling	O
defines	O
the	O
outcome	O
of	O
the	O
effect	O
of	O
TGF	B-GENE
-	I-GENE
beta	E-GENE
on	O
atherosclerosis	O
where	O
Smad1	S-GENE
/	O
5	S-GENE
is	O
responsible	O
for	O
proatherogenic	O
effects	O
,	O
whereas	O
Smad2	S-GENE
/	O
3	S-GENE
regulate	O
atheroprotective	O
effects	O
of	O
TGF	B-GENE
-	I-GENE
beta	E-GENE
.	O
